World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization; 2020.

Google Scholar 

Yao C, Guo HP, Li Q, Zhang XX, Shang YY, Li TX, Wang YF, Xue ZT, Wang L, Li L, et al. Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition. Antimicrob Resist Infect Control. 2021;10(1):126.

Article  PubMed  PubMed Central  Google Scholar 

Andries K, Verhasselt P, Guillemont J, Göhlmann HWH, Neefs JM, Winkler H, Gestel JV, Timmerman P, Zhu M, Lee E, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science. 2005;307(5707):223–7.

Article  CAS  PubMed  Google Scholar 

World Health Organization. Consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2019.

Google Scholar 

Hartkoorn RC, Uplekar S, Cole ST. Cross-Resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2014;58(5):2979–81.

Article  PubMed  PubMed Central  Google Scholar 

Villellas C, Coeck N, Meehan CJ, Lounis N, Jong BD, Rigouts L, Andries K. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline. J Antimicrob Chemother. 2017;72(3):684–90.

CAS  PubMed  Google Scholar 

Nieto Ramirez LM, Quintero Vargas K, Diaz G. Whole genome sequencing for the analysis of drug resistant strains of Mycobacterium tuberculosis: a systematic review for bedaquiline and delamanid. Antibiotics. 2020;9(3):133.

Article  PubMed  PubMed Central  Google Scholar 

Almeida D, Ioerger T, Tyagi S, Li SY, Mdluli K, Andries K, Grosset J, Sacchettinie J, Nuermberger E. Mutations in pepQ confer low-level resistance to bedaquiline and clofazimine in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2016;60(8):4590–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Degiacomi G, Sammartino JC, Sinigiani V, Marra P, Urbani A, Pasca MR. In vitro study of bedaquiline resistance in Mycobacterium tuberculosis multi-drug resistant clinical isolates. Front Microbiol. 2020;11:559469.

Article  PubMed  PubMed Central  Google Scholar 

Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011;38(3):516–28.

Article  CAS  PubMed  Google Scholar 

Zhao YL, Xu SF, Wang LX, Chin DP, Wang SF, Jiang GL, Xia H, Zhou Y, Li Q, Ou XC, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161–70.

Article  CAS  PubMed  Google Scholar 

Xie LX, Wang XB, Zeng J, Zhou ML, Duan XK, Li QM, Zhang Z, Luo HP, Pang L, Li W, et al. Proteome-wide lysine acetylation profiling of the human pathogen Mycobacterium tuberculosis. Int J Biochem Cell Biol. 2015;59:193–202.

Article  CAS  PubMed  Google Scholar 

Cholo MC, Mothiba MT, Fourie B, Anderson R. Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline. J Antimicrob Chemother. 2017;72(2):338–53.

Article  CAS  PubMed  Google Scholar 

Dookie N, Rambaran S, Padayatchi N, Mahomed S, Naidoo K. Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. J Antimicrob Chemother. 2018;73(5):1138–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, Pang Y, Zhang TH, Xian XP, Li Y, Wang R, Wang PT, Zhang M, Wang JY. Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi. China Int J Infect Dis. 2020;99:163–70.

Article  CAS  PubMed  Google Scholar 

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDRTBt, Ahmad N, Ahuja SD, Akkerman W, Alffenaar JWC, Andersonet LF, Baghaei P, Bang D, Barry PM, Bastos ML, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018;392(10150):821–34.

Article  Google Scholar 

Khoshnood S, Goudarzi M, Taki E, Darbandi A, Kouhsari E, Heidary M, Motahar M, Moradi M, Bazyar H. Bedaquiline: current status and future perspectives. J Glob Antimicrob Resist. 2021;25:48–59.

Article  CAS  PubMed  Google Scholar 

Wang GR, Jiang GL, Jing W, Zong ZJ, Yu X, Chen XT, Li WM, Huang HR. Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey. J Infect. 2021;82(3):371–7.

Article  CAS  PubMed  Google Scholar 

Huang HR, Ding N, Yang TT, Li CD, Jia XM, Wang GR, Zhong J, Zhang J, Jiang GL, Wang SQ, et al. Cross-sectional whole-genome sequencing and epidemiological study of multidrug-resistant Mycobacterium tuberculosis in China. Clin Infect Dis. 2019;69(3):405–13.

Article  CAS  PubMed  Google Scholar 

He WC, Liu CF, Liu DX, Ma AJ, Song YM, He P, Bao JJ, Li YC, Zhao B, Fan JL, et al. Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China. J Glob Antimicrob Resist. 2021;26:241–8.

Article  CAS  PubMed  Google Scholar 

Liu YH, Gao MQ, Du J, Wang L, Gao JT, Shu W, et al. Reduced Susceptibility of Mycobacterium tuberculosis to bedaquiline during antituberculosis treatment and its correlation with clinical outcomes in China. Clin Infect Dis. 2021;73(9):e3391–7.

Article  CAS  PubMed  Google Scholar 

Peretokina IV, Krylova LY, Antonova OV, Kholina MS, Kulagina EV, Nosova EY, Safonova SG, Borisov SE, Zimenkov DV. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates. J Infect. 2020;80(5):527–35.

Article  CAS  PubMed  Google Scholar 

Ismail N, Omar SV, Ismail NA, Peters RPH. Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis. Data Brief. 2018;20:1975–83.

Article  CAS  PubMed  PubMed Central  Google Scholar